Related Experiment Video
Updated: Jan 7, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Recurrent cortical intracranial hemorrhage secondary to factor XIII deficiency: case report and literature review
Mahdi Farasati1, Sayyid Ali Hosseini1, Zahra Baghestani2
1Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Background:
Factor XIII (FXIII) deficiency is a rare coagulation disorder that can present in a variety of clinical pictures, including umbilical cord bleeding, poorly healed wounds, and intracranial hemorrhage (ICH). Most of the patients also have prolonged bleeding issues. Here, we present a case of recurrent ICH from the same site due to FXIII deficiency.
Case Report:
The patient is a 24-year-old man who presented with a thunderclap headache and homonymous hemianopia to the hospital. His medical history was only significant for a prior ICH a decade ago. Blood workups were within normal limits. Magnetic resonance imaging (MRI) revealed a heterogeneous, high- to iso-signal in T2 and iso- to high-signal in T1 lesion in the occipital lobe. An angiography was performed, revealing no vascular lesions or pathologic findings. 4 days after the angiography, the hematoma expanded, and the patient started bleeding from the catheter insertion site. After a hematology consultation and running specific tests, FXIII deficiency was detected. Cryoprecipitate therapy for the patient was started, and he was advised to undergo routine FXIII level assessment.
Conclusion:
This case shows the importance of considering coagulation disorders, including FXIII deficiency, in recurrent ICHs, especially when other findings are normal.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

